Adione Terapi Aps: Financial statements 2025
CVR: 41046066
Source: annual report 2025, Danish Business Authority
01/06/2024 – 31/05/2025
Adione Terapi Aps (CVR 41046066) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 24,254. The solvency ratio was 100%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 24,254
- Total Assets
- DKK 24,254
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 0 | 0 | 24 t. | - |
| 2024 | - | 0 | 0 | 24 t. | - |
| 2023 | - | 0 | 0 | 24 t. | - |
| 2022 | - | 0 | 0 | 24 t. | - |
Official annual report
How creditworthy is Adione Terapi Aps?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Adione Terapi Aps
Adione Terapi Aps is a Danish company of the type Anpartsselskab based in København S, founded in 2019. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The management consists of Eva Diana Egom Aagaard. The company is owned by Eva Diana Egom Aagaard. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 24,254.